Connect with us

Crowdfunding

DaVinci Salute Exceeds Crowdfunding Collection Target

The platform DaVinci Salute facilitates patient-professional contact while enabling physicians and psychologists to improve appointment management processes through: scheduling, remote visits and follow-ups, digital support (prescription, medical records, dashboard monitoring of symptoms and initial history). With a secure and immediate payment system.

Published

on

The second equity crowdfunding campaign of MedTech startup DaVinci Salute has concluded, carried out with the aim of raising funds for the technological improvement of the platform. The goal is to invest all its technological and operational resources in the expansion of services aimed at family doctors.

Find more details about the crowdfunding campaign recently completed by DaVinci Health and read the most important financial headlines with the Born2Invest mobile app.

The campaign conducted on BacktoWork24 has found the interest of 42 investors, thanks to which 337% of the initial collection target has been reached

The capital increase of $321,240 (€269,452) allowed DaVinci Salute to exceed $1.19 million (€1 million) in total funding and to obtain a post-money valuation of $9.23 million (€7.75 million). Investors have chosen to support DaVinci Salute’s initiative in a moment of strong growth for the health tech and territorial medicine sector. In the next 5-8 years, in fact, about 80% of physicians will retire, generating a complete generational turnover. At the same time, the number of physicians available on the territory will be reduced by 30-40%, with a consequent increase in waiting times and slow response times.

“DaVinci’s project lies at the heart of everyone’s daily lives: this is why the decision was made to turn to crowdfunding. For example, as demonstrated by the usefulness of tele-monitoring and televisite, the growth of digitalization within the healthcare sector in Italy can represent an important turning point for the management of situations such as the one experienced during the emergency by Covid-19,” commented CEO Stefano Casagrande.

Facilitating the relationship between patient and doctor


Created in 2018 by three young Italian entrepreneurs, it is an innovative startup that operates in the telemedicine sector, having created a secure and certified digital platform (GDPR compliant) – usable on App and WebApp – that allows responding to the need to improve healthcare prevention, cut down waiting lists and reduce the complexities of access to healthcare. The service allows, in fact, to make medical and psychological televisions without waiting lists and from anywhere, simply by smartphone.

SEE ALSO  Ethereum course increases by 36% and DeFi breaks the $4 billion mark

The mission of DaVinci Salute is to facilitate access to healthcare and wellbeing through innovation and digital solutions, in order to become the reference platform that allows people to establish continuous contact with healthcare providers, helping them to regain a complete physical and mental wellbeing.

The crucial future of telemedicine


“Since our inception in 2018, we’ve grown an average of +35% every month, and last year we experienced 2000% growth. Even before the pandemic, we were already one of the leading startups active in telemedicine and digital health, especially in primary care, and this allowed us to be ready to support the national health system immediately from the first days of the Covid emergency by activating multiple pandemic containment initiatives. Consistent with our company’s mission as a startup focused on primary care, we were able to field several initiatives in just a few weeks to support suspected positives, fragile or Covid-19 positive individuals by providing a digital channel for taking care of them, from symptom screening to diagnostics to recovery monitoring.”

Investing in tech R&D


“We plan to invest 70% of our funding in tech research and development. This is because we have shifted our center of gravity to become more and more a tech company, a product startup. Still, in the field of telemedicine, our intention is to continue to specialize in primary care in terms of physical but also mental health, supporting territorial medicine and the relationship between family doctors and citizen.

Another of the actions we want to take is to support the development of network and group medicine. By this we mean groups of doctors who get together to offer wider access to the doctor’s office, coordinating on the opening hours of the clinic and giving availability of virtual access: in this way patients have the opportunity to contact their doctor instead of going to the ER for a white code or risk self-diagnosis online.”

SEE ALSO  Markets May Have Hit a Temporary Top that Could Continue into September

__

(Featured image by Tumisu via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in StartupItalia, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

J. Frank Sigerson is a business and financial journalist primarily covering crypto, cannabis, crowdfunding, technology, and marketing. He also writes about the movers and shakers in the stock market, especially in biotech, healthcare, mining, and blockchain. In the past, he has shared his thoughts on IT and design, social media, pop culture, food and wine, TV, film, and music. His works have been published in Investing.com, Equities.com, Seeking Alpha, Mogul, Small Cap Network, CNN, Technology.org, among others.

Continue Reading